PF-04360365
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for PF-04360365, covering 2009-07-28 to 2024-04-19. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease [Phase 2]